Eldepryl is the brand name for the drug selegiline used in the treatment of parkinson disease. It is classified as a selective monoamine oxidase b inhibitor that prolongs the activity of dopamine in the brain. By inhibiting mao b the medication reduces the breakdown of dopamine allowing higher levels to reach motor neurons. This increase supports the replacement of lost dopaminergic cells and improves motor function in patients with parkinson disease. The physiological processes affected include the regulation of movement pathways in the basal ganglia and the modulation of neurotransmitter balance. The active ingredient selegiline thereby contributes to a more stable dopamine signal which translates into smoother motor coordination and reduced tremor. Overall Eldepryl provides a targeted approach to maintaining dopamine availability and delivering symptomatic relief for individuals with parkinson disease.

Eldepryl is a medication used primarily to manage symptoms of parkinson's disease. It works by inhibiting the enzyme monoamine oxidase type b in the brain. This inhibition slows the breakdown of dopamine, allowing more of the neurotransmitter to remain available. Increased dopamine activity helps improve motor function and reduces stiffness and tremor. The drug also has a mild antioxidant effect that may protect nerve cells from oxidative stress. By preserving dopamine and reducing oxidative damage, Eldepryl can modestly slow disease progression. Overall, its pharmacological action bridges biochemical pharmacology with a therapeutic role in supporting dopamine-dependent pathways.

The most common side effects include headache fatigue nausea dizziness and dry mouth. These symptoms are usually mild and may resolve on their own. They often appear soon after starting a new therapy. Headache is reported frequently across many treatment classes. Nausea can vary in intensity from slight discomfort to more pronounced upset. Dizziness may affect balance and may be monitored. Dry mouth is commonly noted and can be managed with simple measures.

The most common side effects include nausea dizziness headache diarrhea fatigue and mild skin rash. These reactions are usually transient and resolve without intervention. Monitoring symptoms helps identify patterns and triggers. Severity varies among individuals but is generally mild. Persistence of symptoms beyond a short period warrants observation. Overall most occurrences are manageable with supportive measures.